Elekta’s Versa HD radiation therapy system is centerpiece in New Zealand cancer therapy center

New Kathleen Kilgour Centre, now treating patients with Versa HD, also acquires Elekta treatment planning, brachytherapy and oncology information systems

Tauranga New Zealand — Wednesday, November 19, 2014

New Zealand’s new state-of-the-art cancer center, Kathleen Kilgour Centre in Tauranga, began treating patients with the first Versa HD™ system in the country on September 18, officially opening the clinic. Versa HD, Elekta’s latest radiation therapy system, is equipped with advanced beam-shaping and high dose rate technologies to deliver extremely precise treatments in shorter treatment times.

The clinic acquired two Versa HD systems, in addition to Elekta’s (EKTA-B.ST) MOSAIQ® Oncology Information System, Monaco® treatment planning system and microSelectron® brachytherapy system.

The “Kathleen Kilgour Centre is now among the most sophisticated and outstanding hospital facilities in New Zealand,” says Centre managing director Mark Fraundorfer, MD. “Radiation therapy is a critical service for Bay of Plenty patients. Having this advanced equipment here will enable patients to get their treatments closer to home without having to travel to other more distant centers.”

Environmentally friendly

In addition to its high-tech radiotherapy systems, the 32,000 sq ft. (~ 3,000 sq m) facility also is equipped with solar panels to provide clean electrical power and a rainwater harvesting system, substantially reducing Kathleen Kilgour Centre’s environmental impact.

“Sunshine will essentially power the Versa HD systems in addition to the cooling and heating systems in the clinic, so we will be very energy efficient,” Dr. Fraundorfer notes. “We could have just constructed a building in the normal way, but we wanted to create a facility that not only provided comprehensive radiation therapy services, but also one that was as environmentally sustainable as possible.”

 

###

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com Twitter: @Elekta.

Press Releases

For further information, please contact

Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242
Email: gert.vansanten@elekta.com
Time zone: CET: Central European Time

Kris Walmsley, Corporate Communications Manager, Elekta AB
Tel: +46 70 537 9545
Email: kris.walmsley@elekta.com
Time zone: CET: Central European Time